Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.

P Birner; G Oberhuber; J Stani; C Reithofer; H Samonigg; H Hausmaninger; E Kubista; W Kwasny; D Kandioler-Eckersberger; M Gnant; R Jakesz

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.

P Birner, G Oberhuber, J Stani, C Reithofer, H Samonigg, H Hausmaninger, E Kubista, W Kwasny, D Kandioler-Eckersberger, M Gnant, R Jakesz

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

159 Citations (Web of Science)

Original language	English
Pages (from-to)	1669-1675
Journal	CLINICAL CANCER RESEARCH
Volume	7
Issue number	6
Publication status	Published - 2001

Keywords

IN-SITU HYBRIDIZATION
MONOCLONAL-ANTIBODY
GENE AMPLIFICATION
PHASE-II
CHEMOTHERAPY
TAMOXIFEN
ONCOGENE
QUANTITATION
HERCEPTEST
WOMEN

Cite this

Birner, P., Oberhuber, G., Stani, J., Reithofer, C., Samonigg, H., Hausmaninger, H., Kubista, E., Kwasny, W., Kandioler-Eckersberger, D., Gnant, M., & Jakesz, R. (2001). Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. CLINICAL CANCER RESEARCH , 7(6), 1669-1675.

Birner, P ; Oberhuber, G ; Stani, J et al. / Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. In: CLINICAL CANCER RESEARCH 2001 ; Vol. 7, No. 6. pp. 1669-1675.

@article{a053038b78674bfd801d7bf9395f2dea,

title = "Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.",

keywords = "IN-SITU HYBRIDIZATION, MONOCLONAL-ANTIBODY, GENE AMPLIFICATION, PHASE-II, CHEMOTHERAPY, TAMOXIFEN, ONCOGENE, QUANTITATION, HERCEPTEST, WOMEN",

author = "P Birner and G Oberhuber and J Stani and C Reithofer and H Samonigg and H Hausmaninger and E Kubista and W Kwasny and D Kandioler-Eckersberger and M Gnant and R Jakesz",

year = "2001",

language = "English",

volume = "7",

pages = "1669--1675",

journal = "CLINICAL CANCER RESEARCH ",

issn = "1078-0432",

publisher = "Amer Assoc Cancer Research",

number = "6",

}

Birner, P, Oberhuber, G, Stani, J, Reithofer, C, Samonigg, H, Hausmaninger, H, Kubista, E, Kwasny, W, Kandioler-Eckersberger, D, Gnant, M & Jakesz, R 2001, 'Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.', CLINICAL CANCER RESEARCH , vol. 7, no. 6, pp. 1669-1675.

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. / Birner, P; Oberhuber, G; Stani, J et al.
In: CLINICAL CANCER RESEARCH , Vol. 7, No. 6, 2001, p. 1669-1675.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.

AU - Birner, P

AU - Oberhuber, G

AU - Stani, J

AU - Reithofer, C

AU - Samonigg, H

AU - Hausmaninger, H

AU - Kubista, E

AU - Kwasny, W

AU - Kandioler-Eckersberger, D

AU - Gnant, M

AU - Jakesz, R

PY - 2001

Y1 - 2001

KW - IN-SITU HYBRIDIZATION

KW - MONOCLONAL-ANTIBODY

KW - GENE AMPLIFICATION

KW - PHASE-II

KW - CHEMOTHERAPY

KW - TAMOXIFEN

KW - ONCOGENE

KW - QUANTITATION

KW - HERCEPTEST

KW - WOMEN

M3 - Original Article

C2 - 11410505

SN - 1078-0432

VL - 7

SP - 1669

EP - 1675

JO - CLINICAL CANCER RESEARCH

JF - CLINICAL CANCER RESEARCH

IS - 6

ER -

Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H et al. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. CLINICAL CANCER RESEARCH . 2001;7(6):1669-1675.